| Announce Date | 10/27/2025 |
| EPS Normalized Actual | $10.96 (Beat by $2.85) |
| EPS GAAP Actual | $10.96 (Beat by $2.85) |
| Revenue Actual | $3.519B |
| Revenue Surprise | Beat by $3519M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $4.44902 |
| EPS GAAP Estimate | $4.44902 |
| Revenue Estimate | $2.738925531B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 21.88 | 5.42 | 21.22126 | 22.80901 | 1 |
| Dec 2026 | 1.07931 | 109.92 | 1.03156 | 1.16497 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 10.1 | 4.00135 | 3.519B | 1.11% | 317.27M |
| FQ2 2025 (Jun 2025) | 0.1 | -5.68227 | 3.039B | -0.3% | -132.43M |
| FQ1 2025 (Mar 2025) | -14.35 | -12.1574 | 2.43B | -4.98% | -182.52M |
| FQ4 2024 (Dec 2024) | -55.15 | -55.15 | 2.663B | -3.79% | 2663M |
| FQ3 2024 (Sep 2024) | 6.68 | 6.68 | 3.48B | -2.41% | 3480M |
| FQ2 2024 (Jun 2024) | 0.39 | 0.39 | 3.048B | -2.46% | 3048M |
| FQ1 2024 (Mar 2024) | -3.2 | -3.2 | 2.551B | -0.24% | 2551M |
| FQ4 2023 (Dec 2023) | 6.6 | 6.6 | 2.764B | 100% | 2764M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
4.44902
Consensus Revenue Estimates
2.738925531B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 1 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 1 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 1 |
| FQ4 2026 (Oct 2026) | 14.1368 | -- | 11.49403 | 14.96324 | 3 |
| FQ3 2026 (Jul 2026) | 8.9553 | -12.78 | 7.28118 | 9.47883 | 3 |
| FQ2 2026 (Jun 2026) | 8.95534 | 98.88 | 6.89999 | 9.50869 | 3 |
| FQ1 2026 (Mar 2026) | 4.44902 | 422.54 | 3.42792 | 4.72393 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.81B | -- | 2.79B | 2.83B | 2 |
| FQ3 2027 (Sep 2027) | 3.64B | -- | 3.61B | 3.66B | 2 |
| FQ2 2027 (Jun 2027) | 3.15B | -- | 3.12B | 3.17B | 2 |
| FQ1 2027 (Mar 2027) | 2.5B | -- | 2.48B | 2.52B | 2 |
| FQ4 2026 (Oct 2026) | 3.84B | -- | 3.29B | 4.01B | 2 |
| FQ3 2026 (Jul 2026) | 3.4B | -3.43 | 2.91B | 3.56B | 2 |
| FQ2 2026 (Jun 2026) | 3.4B | 10.68 | 2.8B | 3.56B | 2 |
| FQ1 2026 (Mar 2026) | 2.74B | 11.28 | 2.26B | 2.87B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 6.09865 | 10.1 | 4.00135 | 39.62% |
| FQ2 2025 (Jun 2025) | 5.78227 | 0.1 | -5.68227 | -5682.27% |
| FQ1 2025 (Mar 2025) | -2.1926 | -14.35 | -12.1574 | 84.72% |
| FQ4 2024 (Dec 2024) | -55.15 | -55.15 | 100% | |
| FQ3 2024 (Sep 2024) | 6.68 | 6.68 | 100% | |
| FQ2 2024 (Jun 2024) | 0.39 | 0.39 | 100% | |
| FQ1 2024 (Mar 2024) | -3.2 | -3.2 | 100% | |
| FQ4 2023 (Dec 2023) | 6.6 | 6.6 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.2B | $3.52B | $317.27M | 9.02% |
| FQ2 2025 (Jun 2025) | $3.17B | $3.04B | $-132.43M | -4.36% |
| FQ1 2025 (Mar 2025) | $2.61B | $2.43B | $-182.52M | -7.51% |
| FQ4 2024 (Dec 2024) | $0B | $2.66B | $2663M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.48B | $3480M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.05B | $3048M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.55B | $2551M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.76B | $2764M | 100% |